Neuromodulation Technologies - A Strategic Perspective (TechVision)

USD 4,950.00

* Required Fields

USD 4,950.00


Be the first to review this product

Over the past decade, global industry leaders offering neuromodulation technologies have been largely successful in implementing large scale value stream transformation programs in setting a mature cost-to-serve model. However, understanding the gaps between OEM initiatives in delivering value to care payers and payer demands have been limited. This research service offers a strategic perspective on the industry, analyzing the gaps between technology push-pull factors that are poised to enable OEMs sustain both volume growth and margin. This research also examines how OEMs can shift from a value-to-cost model to a value-to-serve business model, which plays a lead role in delivering personalized value to healthc

Table of Contents

1.0 Executive Summary1.1 Scope of Research1.2 Research Methodology2.0 Key Findings2.1 Transferring Cost Efficiencies across the Value Chain2.2 IP Filings Focus on Minimally Invasive Therapies2.3 Clinical Trials to Diversify Product Pipeline2.4 Differentiate Products by Building a Value-driven Organization3.0 Technology Trends and Analysis3.1 Invasive, Minimally Invasive and Non-Invasive Neuromodulation Technologies3.2 High Market Demand for Non-Invasive Methods and Therapies for Lifestyle Disorders3.3 Spinal Cord and Deep Brain Stimulation Systems, Global, 20163.4 Vagus Nerve and Other Stimulation Systems, Global, 20163.5 NPD Efforts Focus on Miniaturization of Implants3.6 Objectives of OEMs Are Aligned to Delivering Personalized Value to Payers3.7 Focus on Creating Effective Collaboration among Payers Drive Channel Growth3.8 Neuromodulation Systems, Prices, Global, 20163.9 Assessment of Components of Neuromodulation Systems3.10 Analytical Hierarchy Process: Prioritization of Neuromodulation Technologies3.11 Performance of Pulse Generator and Lead Precision Is of High Priority3.12 Functionality of Device Controller and Programmer Are of Least Priority3.13 Improving the Longevity of Power Supplies and Lead Flexibility3.14 Payer Preference to Minimally Invasive Therapies for Chronic Conditions4.0 Industry Trends and Analysis4.1 80% of Market Share Is Owned by Four Companies4.2 Cost-efficient Value Chain and Consolidation Efforts Drive Profitable Growth4.3 Better Patient-Physician Collaboration Drive Technology Growth4.4 Consolidation Trends Pull Prospective Investments within the Global Industry4.5 OEMs Race against VC/PE Firms to Invest in Neuromodulation Technologies4.6 Increase in Cross-selling Agreements with Pharmaceutical Companies4.7 OEMs Place a Premium during Commercialization of Co-created Products4.8 Established Mid-size Firms Are Partnership Targets in Emerging Markets4.9 Backward Integration Efforts of OEMs Will Deliver Personalized Value4.10 VC and Major Pharmaceutical Firms Influence Growth in Delivery of Quality Care5.0 Strategy Assessment5.1 Centricity between Cost Efficiency and Market Maturity Enabled Customer Value5.2 Neuromodulation: Key Growth Strategies for a Value-Driven Business Model, Global, 20165.3 Value-for-Cost Business Model: OEMs Focus on Cost Savings within the Value-Chain6.0 Analyst Insights6.1 A Robust Operations Analytics Framework to Drive Quality Patient Care6.2 Strategic Partnerships Deliver Sustainable Growth and Value Proposition7.0 List of Key Patents7.1 Boston Scientific Leads in IP Creation Activities Worldwide7.2 Key Patents: Cantilever Electrodes for Transdermal and Transcranial Stimulation7.3 Key Patents: Optogenetic Therapies for Movement Disorders7.4 Key Patents: Minimally Invasive Implantable Neurostimulation Systems7.5 List of Key Industry ParticipantsLegal Disclaimer8.0 Appendix8.1 Analytical Hierarchical Process 8.2 Explanation of Benchmarking Criteria8.3 Liberatore’s Rating Scale9.0 The Frost & Sullivan Story9.1 The Frost & Sullivan Story9.2 Value Proposition: Future of Your Company & Career9.3 Global Perspective9.4 Industry Convergence9.5 360º Research Perspective9.6 Implementation Excellence9.7 Our Blue Ocean Strategy

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.